These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 33224869

  • 1. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
    Luo Q, Wang C, Peng B, Pu X, Cai L, Liao H, Chen K, Zhang C, Cheng Y, Pan M.
    Front Oncol; 2020; 10():1758. PubMed ID: 33224869
    [Abstract] [Full Text] [Related]

  • 2. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J, Luo Y, Xi X, Li H, Li S, Zheng L, Yang D, Cai Z.
    Front Oncol; 2022; 12():931140. PubMed ID: 36465354
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy.
    Qiu Y, Zhang X, Deng X, Zhang R, Cai Z, Zhang Z, Liu H.
    Eur J Surg Oncol; 2022 May; 48(5):1039-1045. PubMed ID: 34836729
    [Abstract] [Full Text] [Related]

  • 5. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.
    Guan Y, Xu F, Tian J, Gao K, Wan Z, Wang Y, Gao M, Wang Z, Chong T.
    BMC Cancer; 2021 Jul 17; 21(1):826. PubMed ID: 34271857
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
    Ju M, Gao Z, Gu G, Huang H, Sun A, Zheng C, Li H, Zhang Y, Li K.
    BMC Cancer; 2023 Dec 12; 23(1):1224. PubMed ID: 38087278
    [Abstract] [Full Text] [Related]

  • 9. Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer.
    Wang Y, Liu Y, Zhang Z, Lu B, Gao Y, Tong L, Hu M, Lin PP, Li B, Zhang T.
    BMC Cancer; 2023 Jun 22; 23(1):578. PubMed ID: 37349714
    [Abstract] [Full Text] [Related]

  • 10. Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma.
    Wang C, Luo Q, Huang W, Zhang C, Liao H, Chen K, Pan M.
    Front Oncol; 2021 Jun 22; 11():686365. PubMed ID: 34178679
    [Abstract] [Full Text] [Related]

  • 11. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype.
    Yu JJ, Shu C, Yang HY, Huang Z, Li YN, Tao R, Chen YY, Chen Q, Chen XP, Xiao W.
    Front Oncol; 2021 Jun 22; 11():734564. PubMed ID: 34722281
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis.
    Zhu HH, Liu YT, Feng Y, Zhang LN, Zhang TM, Dong GL, Xing PY, Wang HY, Shi YK, Hu XS.
    Thorac Cancer; 2021 Oct 22; 12(20):2749-2757. PubMed ID: 34423906
    [Abstract] [Full Text] [Related]

  • 16. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
    Zhao X, Zhao J, Tao L, Pan Y, Yang L, Zhang X, Yuan J, Zhu H.
    J Gastrointest Oncol; 2021 Dec 22; 12(6):3050-3060. PubMed ID: 35070429
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM, Jansson S, Bendahl PO, Levin Tykjaer Jörgensen C, Loman N, Graffman C, Lundgren L, Aaltonen K, Rydén L.
    Breast Cancer Res; 2018 Jun 08; 20(1):48. PubMed ID: 29884204
    [Abstract] [Full Text] [Related]

  • 18. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z, Wang C, Ye Z, Austin L, Civan J, Hyslop T, Palazzo JP, Jaslow R, Li B, Myers RE, Jiang J, Xing J, Yang H, Cristofanilli M.
    Breast Cancer Res Treat; 2015 Dec 08; 154(3):563-71. PubMed ID: 26573830
    [Abstract] [Full Text] [Related]

  • 19. Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.
    Zhao L, Song J, Sun Y, Ju Q, Mu H, Dong X, Ding J, Liu Y, Wang X, Sun L, Wu J, Jiao Y, Lu S, Zhao X.
    Cancer Med; 2023 Jul 08; 12(13):13912-13927. PubMed ID: 37337648
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.